The present application claims priority to and the benefit of U.S. application Ser. No. 12/180,324, entitled, “Dialysis System With Flow Regulation Device”, filed Jul. 25, 2008, now U.S. Pat. No. 10,265,454, the entire contents of which are incorporated herein by reference and relied upon.
The present disclosure relates generally to a dialysis system. More specifically, the present disclosure relates to a dialysis system including a flow regulation device for regulating the fluid flow to a dialysis device.
Hemodialysis uses a dialysis fluid to remove waste products from a patient's blood. One of the drawbacks of performing home hemodialysis (hemodialysis in a patient's home) is the need for a dedicated water treatment, which includes equipment, water connection and drainage. Installing and using those components is a difficult and cumbersome task that can require a patient's home to be modified. Nevertheless, there are benefits to daily hemodialysis treatments versus bi- or tri-weekly visits to a treatment center. In particular, a patient receiving more frequent treatments removes more toxins, waste products, and excess water more frequently, thus reducing fluctuations in blood chemistry and blood pressure, than a patient receiving less frequent but perhaps longer treatments.
Peritoneal dialysis utilizes a sterile dialysis solution, which is infused into a patient's peritoneal cavity and into contact with the patient's peritoneal membrane. Waste, toxins and excess water pass from the patient's bloodstream through the peritoneal membrane and into the used dialysate. The spent dialysate is later drained from the patient's peritoneal cavity to remove the waste, toxins and excess water from the patient. Patients undergoing peritoneal dialysis also face difficulties in terms of the volume of treatment fluid needed.
Dialysis machines require large (ranging from 20 to 200 liters per treatment) amounts of water to provide the dialysis fluid used in the machine. Further, the fluid demand of a dialysis machine is not constant and varies with the cycling of the machine. In the institutional setting, most water systems for dialysis supply a hydraulic branch with very large volumes of water. The excess water and large number of individual dialysis systems connected to the branch mitigate the variable fluid demand of each individual machine. Moreover, many water systems include large tanks capable of holding several thousand liters to provide a backup reservoir to account for changes in draw rate.
In a home setting, a single dialysis device may be connected to a single water supply without any fluid reservoir in the circuit. Thus, the device lacks the water reserve capabilities previously described for systems with large numbers of dialysis machines. Because dialysis machines do not draw a constant flow of water but rather start and stop, problems are presented. The fluid supply to the device needs to have a flow capacity that is at least as great as the maximum instantaneous draw rate of the dialysis device, which can be significantly greater than the average fluid demand of the dialysis device. Further, if the water source provides a continuous flow of fluid, a significant amount of dialysis fluid is produced but not used for dialysis, and thus is wasted.
The present disclosure provides a dialysis system including a flow regulation device for regulating the fluid flow to the dialysis device.
In an embodiment, a dialysis system includes a dialysis machine with a variable fluid demand including at least a lower demand and a higher demand. A fluid source is in fluid communication with the dialysis machine and provides fluid to the dialysis machine at a fluid flow rate. A flow regulation device includes a fluid inlet in fluid communication with the fluid source and a fluid outlet in fluid communication with the dialysis machine. The flow regulation device is operable to expand and contract to provide a variable internal volume. The flow regulation device expands when the dialysis machine has the lower demand and contracts when the dialysis machine has the higher demand. The fluid may be dialysate or purified water.
In an embodiment, the flow regulation device includes a first wall and a second wall disposed opposite each other between the fluid inlet and the fluid outlet to define in part the internal volume, wherein the first wall and the second wall are composed of a compliant material. The first wall and the second wall move away from each other when the device expands and move towards each other when the device contracts.
In another embodiment, the flow regulation device includes a pleated wall, the pleated wall expanding outwardly to provide the variable internal volume.
In an embodiment, the maximum internal volume of the flow regulation device is between 25 mL and 200 mL. The maximum internal volume of the flow regulation device may be between 50 ml and 100 ml.
In an embodiment, the fluid source comprises a system for preparing the fluid from a water source.
In an embodiment, the fluid flow rate from the fluid source is generally constant. The fluid flow rate from the fluid source may be generally equal to an average fluid demand of the dialysis machine.
In an embodiment, the dialysis machine is a hemodialysis machine.
In another embodiment, a dialysis system includes a flow regulation device that contains a gas providing a gas volume. The gas volume is regulated to provide a variable fluid volume. The flow regulation device provides a maximum fluid volume between 25 mL and 200 mL. The gas volume decreases when the dialysis machine has the lower demand and increases when the dialysis machine has the higher demand.
In an embodiment, the flow regulation device comprises a rigid canister. The gas volume may be regulated by discharging gas from the flow regulation device and taking gas into the flow regulation device. The dialysis system may include a filter for filtering gas entering the flow regulation device.
In another embodiment, a dialysis system includes a dialysis machine with a variable fluid demand. A fluid source is in fluid communication with the dialysis machine and provides fluid to the dialysis machine at a fluid flow rate. A controller is in communication with the dialysis machine and configured to send a control signal indicative of a fluid demand of the dialysis machine. A flow control mechanism is in communication with the controller and operable to receive the control signal to control the fluid flow rate based on the fluid demand of the dialysis machine.
In another embodiment, a method of controlling the flow of fluid to a dialysis machine includes providing the dialysis machine. The dialysis machine has a variable fluid demand including at least a lower demand and a higher demand. A fluid source is in fluid communication with the dialysis machine and provides fluid to the dialysis machine. A flow control mechanism is provided to control flow from the fluid source. The flow of fluid to the dialysis machine is controlled by sending a signal from the dialysis machine, wherein the signal is indicative of a fluid demand of the dialysis machine, and using the signal to regulate the flow control mechanism to control the fluid flow based on the fluid demand of the dialysis machine.
In an embodiment, the signal is indicative of a current fluid demand of the dialysis machine. Alternatively, the signal is indicative of an anticipated future fluid demand of the dialysis machine.
In an embodiment, the dialysis machine includes a pump and a pump controller, wherein the signal is provided by the pump controller. The signal may be provided by wire. Alternatively, the signal may be provided wirelessly.
Additional features and advantages are described herein, and will be apparent from the following Detailed Description and the figures.
The present disclosure is directed to a flow regulation device for making dialysis easier for a dialysis patient at home. While the embodiments discussed are not limited to home applications, it will be readily apparent that an efficient, safe, and conveniently-sized dialysis system is most useful in a home application. Nevertheless, the systems disclosed herein may also be used in larger institutions, such as hospitals or clinics, and may be used as back-up or reserve capacity in the event that the supply chain is somehow interrupted.
A general hemodialysis system is depicted in
As shown in
One system 60 for producing dialysate to provide fluid for the dialysis fluid source 10 is depicted in
In this embodiment, the A concentrate pump 62 pumps A concentrate to mixing vessel 64 through line 62a, the vessel not filled but retaining an air gap at its top, while the correct ratio of water also flows to the vessel through line 61e. After the water and the A concentrate are mixed, the mixture is deaerated by spraying using precision metering pump 64a, nozzle 64c, and air trap 64b. Other embodiments such as a simple restriction creating a starved intake to pump 64a, could be substituted for the sprayer to remove the air from the solution. The mixture is monitored by temperature and conductivity sensors 64d, 64e. Vessel 64 includes a level sensor L. The deaerated acid mixture is then sent to the B mix chamber 65, where B concentrate from the B concentrate pump through line 63b is added, in this case in-line. The B mix chamber 65 is equipped with a second conductivity sensor 66 to monitor the quality of the finished dialysis solution.
The dialysis solution is then pumped by supply pump 67 through filter 67a, to remove particles larger than 150μ. Control valve 68 controls the flow of dialysis solution from system 60. If the correct level of continuity has not been achieved, the freshly-prepared dialysis solution may be recycled as desired through the filter and the mixing chamber, as shown, until the proper mixing and purity has been achieved. The dialysis solution can then be pumped through a final filter, endotoxin filter 69, on its way to being used. The endotoxin filter is intended to remove endotoxins and bacteria, or fragments of bacteria, such as E. coli and P. aeruginosa. This filter could be an ultrafilter such as those made by Medica Mirandolla Italy or a charged membrane microfilter such as those made by Pall, Long Island, N.Y., USA.
The process described above is only one method for preparing a dialysis solution. Other dialysis solutions may be used, including those requiring an osmotic agent, such as a small amount of dextrose, glucose, sodium or potassium polyacrylate, or mixtures of these, or other component. These solutions are prepared in generally similar ways, some embodiments using powders, some using concentrates, some using solutions. Any such embodiments are intended to fall within the scope of the present disclosure. Embodiments using powders may require a conventional stirred-tank vessel, or vessel suitable for mixing powders using a stirrer or using flow, often turbulent flow, to insure a good mixing. For home use, this may be any suitable mixer capable of maintaining and preserving sterility.
The flow regulation device 40 includes a first wall 46 and a second wall 48 disposed opposite each other between the fluid inlet and the fluid outlet. Walls 46, 48 define in part the internal volume 45. The walls 46, 48 move away from each other when the device expands and towards each other when the device contracts. The walls 46, 48 are composed of a compliant material so that they may expand and contract depending on the flow requirements of the dialysis device. Suitable compliant materials include elastomers and plastics, such as natural rubber latex, PVC, polyurethane, or silicone.
The dialysis machine 30 may operate at a typical average flow rate of 500 ml/min, but the given instantaneous demand rate may be between 0 ml/min and 1000 ml/min. Thus, the lower fluid demand may be 0 ml/min, and the higher fluid demand may be 1000 ml/min. The fluid flow rate from the fluid source 10 is preferably generally equal to the average dialysis fluid demand of the dialysis machine 30. The flow regulation device 40 may provide a maximum internal volume between 25 ml and 200 ml, preferably between 50 mL and 100 mL. Thus, the flow regulation device 40 may provide for pulses of no flow and maximum flow of about 6-10 seconds. In one embodiment, the dialysis machine provides a flow cycle of between 5 and 60 seconds of fluid demand, and between 0.5 and 30 seconds of no fluid demand.
The flow regulation devices 40, 50 may be easily sanitized between uses. Because the inner surfaces of the flow regulation devices 40, 50 are exposed to fluid (which may be a disinfecting solution), it is easy to ensure that the entire flow circuit has been disinfected.
The systems described herein provide significant advantages over current systems. By using a flow regulation device, changes in draw rate are smoothed so that the fluid supply 10 only needs to supply dialysis fluid at the average draw rate of the dialysis machine 30, not at the peak draw rate. The flow regulation devices 40, 50, 70 take up very little space and do not require the large tank volumes of conventional systems.
In another aspect, a dialysis system 10 uses a flow control method to accommodate the variations in fluid demand of the dialysis machine 30. The system includes a data connection between the dialysis machine 30 and the fluid source 10. The data connection provides a signal from the dialysis machine 30 to the fluid source 10 to adjust the flow setting of fluid from the fluid source 10. The flow setting may include a simple on/off control or a more precise flow control. The signal may be indicative of a current fluid demand of the dialysis machine 30, or the anticipated future demand. The dialysis machine 30 may include a control mechanism for its pumps. Based on the current and future flow need of the pumps, the dialysis machine 30 specifies the desired flow rate of the dialysis fluid. The output of the fluid source 10 is regulated to meet the real-time demand of the dialysis machine 30.
For example, the dialysis machine 30 sends a command signal to a valve or other flow setting to open the valve or provide a certain flow rate. Dialysis fluid (or purified water) from the fluid source 10 is then provided at the desired flow rate. The fluid source 10 would typically produce the fluid at the peak rate needed. When the fluid demand of the dialysis machine 30 is lowered, the dialysis machine 30 sends a command to slow or stop the production of dialysis fluid. The dialysis system may be programmed to anticipate the demand of the dialysis machine 30 so that there is no lag time between the dialysis fluid demand of the dialysis machine 30 and the desired flow rate of dialysis fluid from the fluid source 10. The connection between the dialysis machine 30 and the fluid source 10 may be provided by any type of data communication link, including wired, radio, infrared, Bluetooth, and the like.
In another embodiment, a system uses a fluid connection to convey information from the dialysis machine 30 to the fluid source 10. When the dialysis machine 30 draws fluid at the high rate, the fluid source 10 experiences a reduced pressure on an outlet line. A pressure transducer may be used to detect this pressure drop and increase the fluid generation rate accordingly. When the dialysis machine 30 reduces the draw rate, the pressure on the outlet line of the fluid source 10 will increase, which can be detected with the same pressure sensor, leading to a reduction in flow rate. This embodiment provides another means of conveying flow rate information.
The data connection allows the flow rate of the fluid from the fluid source 10 to be synchronized with the draw rate of the dialysis device 30. This prevents the fluid source (such as system 60) from having to consistently run at the peak draw rate of the dialysis machine 30. The life span of the components of the dialysis solution preparation system (such as pumps, filters, sensors, and so forth) can be extended by reducing their total use. Further, the fluid (whether dialysate or water) that is produced but not used for dialysis (and thus wasted) is limited, because it is not pumped when it is not needed.
It should be understood that various changes and modifications to the presently preferred embodiments described herein will be apparent to those skilled in the art. Such changes and modifications can be made without departing from the spirit and scope of the present subject matter and without diminishing its intended advantages. It is therefore intended that such changes and modifications be covered by the appended claims.
Number | Name | Date | Kind |
---|---|---|---|
422936 | Hanson | Mar 1890 | A |
1627257 | Stevens | May 1927 | A |
2307566 | Browne | Jan 1943 | A |
2315179 | Allender | Mar 1943 | A |
2393838 | Tarbox | Jan 1946 | A |
2474512 | Bechtold et al. | Jun 1949 | A |
2565374 | Kitchel | Aug 1951 | A |
2773455 | Mercier | Dec 1956 | A |
2927658 | Slater, Jr. | Mar 1960 | A |
3252623 | Corbin et al. | May 1966 | A |
3527700 | Goldhaber | Sep 1970 | A |
3658445 | Pulman et al. | Apr 1972 | A |
3741692 | Rupp | Jun 1973 | A |
3778195 | Bamberg | Dec 1973 | A |
3804107 | Kozlov et al. | Apr 1974 | A |
3805817 | Smith | Apr 1974 | A |
3818934 | Borsanyi | Jun 1974 | A |
3902490 | Jacobsen et al. | Sep 1975 | A |
3974854 | Kurpanek | Aug 1976 | A |
3986956 | Anno | Oct 1976 | A |
4003379 | Ellinwood, Jr. | Jan 1977 | A |
4077405 | Haerten et al. | Mar 1978 | A |
4081372 | Atkin et al. | Mar 1978 | A |
4107039 | Lindsay, Jr. et al. | Aug 1978 | A |
4191184 | Carlisle | Mar 1980 | A |
4193068 | Ziccardi | Mar 1980 | A |
4209014 | Sefton | Jun 1980 | A |
4258711 | Tucker et al. | Mar 1981 | A |
4293961 | Runge | Oct 1981 | A |
4345594 | Bisera et al. | Aug 1982 | A |
4360019 | Portner et al. | Nov 1982 | A |
4360324 | Ohara et al. | Nov 1982 | A |
4392791 | Mandroian | Jul 1983 | A |
4445829 | Miller | May 1984 | A |
4489750 | Nehring | Dec 1984 | A |
4493706 | Borsanyi et al. | Jan 1985 | A |
4501583 | Troutner | Feb 1985 | A |
4525165 | Fischell | Jun 1985 | A |
4599165 | Chevallet | Jul 1986 | A |
4604090 | Reinicke | Aug 1986 | A |
4610702 | Krantz | Sep 1986 | A |
4653987 | Tsuji et al. | Mar 1987 | A |
4662829 | Nehring | May 1987 | A |
4671792 | Borsanyi | Jun 1987 | A |
4673391 | Kondo et al. | Jun 1987 | A |
4684368 | Kenyon | Aug 1987 | A |
4687423 | Maget et al. | Aug 1987 | A |
4687468 | Gianturco | Aug 1987 | A |
4714462 | DiDomenico | Dec 1987 | A |
4728265 | Cannon | Mar 1988 | A |
4741678 | Nehring | May 1988 | A |
4744786 | Hooven | May 1988 | A |
4767526 | Vantard | Aug 1988 | A |
4838887 | Idriss | Jun 1989 | A |
4871351 | Feingold | Oct 1989 | A |
4954046 | Irvin et al. | Sep 1990 | A |
4969936 | Schweigert et al. | Nov 1990 | A |
4978338 | Melsky et al. | Dec 1990 | A |
4979441 | Welch et al. | Dec 1990 | A |
5053031 | Borsanyi | Oct 1991 | A |
5057081 | Sunderland et al. | Oct 1991 | A |
5088904 | Okada | Feb 1992 | A |
5152680 | Okada | Oct 1992 | A |
5176644 | Srisathapat et al. | Jan 1993 | A |
5244463 | Cordner, Jr. et al. | Sep 1993 | A |
5247434 | Peterson et al. | Sep 1993 | A |
5263935 | Hessel | Nov 1993 | A |
5290158 | Okada | Mar 1994 | A |
5387188 | Watson | Feb 1995 | A |
5421208 | Packard et al. | Jun 1995 | A |
5522998 | Polaschegg | Jun 1996 | A |
5544651 | Wilk | Aug 1996 | A |
5554011 | Bales et al. | Sep 1996 | A |
5562429 | Romstad et al. | Oct 1996 | A |
5591344 | Kenley et al. | Jan 1997 | A |
5607418 | Arzbaecher | Mar 1997 | A |
5730722 | Wilk | Mar 1998 | A |
5817076 | Fard | Oct 1998 | A |
5868168 | Mott et al. | Feb 1999 | A |
5871478 | Berrigan | Feb 1999 | A |
6058958 | Benkowski et al. | May 2000 | A |
6089837 | Cornell | Jul 2000 | A |
6110427 | Uffenheimer | Aug 2000 | A |
6159160 | Hsei et al. | Dec 2000 | A |
6228047 | Dadson | May 2001 | B1 |
6234773 | Hill et al. | May 2001 | B1 |
6280408 | Sipin | Aug 2001 | B1 |
6290681 | Brown | Sep 2001 | B1 |
6305919 | Staton et al. | Oct 2001 | B1 |
6312409 | Gross | Nov 2001 | B1 |
6319245 | Berrigan | Nov 2001 | B1 |
6386046 | Mattar | May 2002 | B1 |
6426056 | Taylor | Jul 2002 | B2 |
6471686 | Berrigan | Oct 2002 | B1 |
6537268 | Gibson et al. | Mar 2003 | B1 |
6558343 | Neftel | May 2003 | B1 |
6638263 | Theeuwes et al. | Oct 2003 | B1 |
6656355 | Sano | Dec 2003 | B2 |
6669455 | Welch | Dec 2003 | B2 |
6673376 | Knerr et al. | Jan 2004 | B1 |
6723062 | Westberg et al. | Apr 2004 | B1 |
6746606 | Pfeil et al. | Jun 2004 | B2 |
6749818 | Sano et al. | Jun 2004 | B2 |
6752928 | Pfeil et al. | Jun 2004 | B2 |
6758975 | Peabody et al. | Jul 2004 | B2 |
6814869 | Brandl et al. | Nov 2004 | B2 |
6837693 | Welch | Jan 2005 | B2 |
6861033 | Mullins et al. | Mar 2005 | B2 |
6997942 | Machold et al. | Feb 2006 | B2 |
7018361 | Gillespie, Jr. et al. | Mar 2006 | B2 |
7018375 | Berrigan | Mar 2006 | B2 |
7025750 | Brugger et al. | Apr 2006 | B2 |
7048522 | Bradford, Jr. | May 2006 | B2 |
7108790 | Collins et al. | Sep 2006 | B2 |
7150711 | Nusser et al. | Dec 2006 | B2 |
7175649 | Machold et al. | Feb 2007 | B2 |
7208092 | Micheli | Apr 2007 | B2 |
7241378 | Ikeda | Jul 2007 | B2 |
7290680 | Henry et al. | Nov 2007 | B2 |
7306736 | Collins et al. | Dec 2007 | B2 |
7326564 | Lundell et al. | Feb 2008 | B2 |
7544300 | Brugger et al. | Jun 2009 | B2 |
7563244 | Kent et al. | Jul 2009 | B2 |
7749393 | Brugger et al. | Jul 2010 | B2 |
7798997 | Kamen et al. | Sep 2010 | B2 |
7976711 | Brugger et al. | Jul 2011 | B2 |
8202420 | Brugger et al. | Jan 2012 | B2 |
8192387 | Brugger et al. | Jun 2012 | B2 |
8409445 | Levin et al. | Apr 2013 | B2 |
8460558 | Brugger et al. | Jun 2013 | B2 |
8496824 | Remkes et al. | Jul 2013 | B2 |
8517597 | Shreve et al. | Aug 2013 | B2 |
8540875 | Levin et al. | Sep 2013 | B2 |
8545428 | Burbank et al. | Oct 2013 | B2 |
8585907 | Raiford et al. | Nov 2013 | B2 |
8617134 | Brehm et al. | Dec 2013 | B2 |
8617393 | Remkes et al. | Dec 2013 | B2 |
8671996 | Weilhoefer et al. | Mar 2014 | B2 |
8673139 | Hedmann et al. | Mar 2014 | B2 |
8678224 | Dumont D'Ayot et al. | Mar 2014 | B2 |
8679348 | Burbank et al. | Mar 2014 | B2 |
8715214 | Kopperschmidt | May 2014 | B2 |
8821719 | Becker | Sep 2014 | B2 |
8870811 | Gavin et al. | Oct 2014 | B2 |
8882737 | Graf et al. | Nov 2014 | B2 |
9022969 | Helmore et al. | May 2015 | B2 |
9220828 | Coates | Dec 2015 | B2 |
9470341 | Brehm et al. | Oct 2016 | B2 |
9636444 | Burbank et al. | May 2017 | B2 |
9700663 | Burbank et al. | Jul 2017 | B2 |
9861733 | Burbank et al. | Jan 2018 | B2 |
9983101 | Neftel | May 2018 | B2 |
10076597 | Heyes | Sep 2018 | B2 |
10130746 | Burbank et al. | Nov 2018 | B2 |
10420871 | Burbank et al. | Sep 2019 | B2 |
20020088751 | Rosenqvist | Jul 2002 | A1 |
20020088752 | Balschat et al. | Jul 2002 | A1 |
20020127736 | Chou et al. | Sep 2002 | A1 |
20030195454 | Wariar | Oct 2003 | A1 |
20040019320 | Childers et al. | Jan 2004 | A1 |
20040082903 | Micheli | Apr 2004 | A1 |
20050038325 | Moll | Feb 2005 | A1 |
20050131332 | Kelly | Jun 2005 | A1 |
20060236756 | Rinaldi et al. | Oct 2006 | A1 |
20070135758 | Childers et al. | Jun 2007 | A1 |
20070158267 | Micheli | Jul 2007 | A1 |
20070278155 | Lo et al. | Dec 2007 | A1 |
20080015493 | Childers et al. | Jan 2008 | A1 |
20170203022 | Burbank et al. | Jul 2017 | A1 |
20170281846 | Manda et al. | Oct 2017 | A1 |
20190046713 | Burbank et al. | Feb 2019 | A1 |
20190076589 | Burbank et al. | Mar 2019 | A1 |
20190275226 | Burbank et al. | Sep 2019 | A1 |
Number | Date | Country |
---|---|---|
2181494 | Apr 1987 | EP |
0 816 677 | Jan 1998 | EP |
92018048 | Nov 1992 | WO |
2005025726 | Mar 2005 | WO |
2006008866 | Jan 2006 | WO |
Entry |
---|
Mexico Office Action Application No. MX/a/2013/014819 dated Mar. 2, 2021—3 pages. |
European Search Report Application No. 18198718.1-1115 / 3453413 dated May 20, 2019—10 pages. |
Mexican Office Action Application No. MX/a/2013/014819 dated Oct. 11, 2019—4 pages. |
International Search Report and Written Opinion for International Application No. PCT/US2009/030299 dated May 29, 2009. |
International Search Report and Written Opinion for International Application No. PCT?US2009/047585 dated Feb. 1, 2010. |
International Search Report and Written Opinion for PCT/US2008/066101 dated Feb. 12, 2009. |
Non-Final Office Action for U.S. Appl. No. 11/941,840 dated Jul. 24, 2009. |
Final Office Action for U.S. Appl. No. 11/941,840 dated Feb. 8, 2010. |
Non-Final Office Action for U.S. Appl. No. 11/941,840 dated Sep. 17, 2010. |
Notification of Transmittal of the International Preliminary Report on Patentability for International Application No. PCT/US2009/047585 dated Oct. 12, 2010. |
Canadian Office Action dated Jul. 17, 2015 in corresponding Canadian Patent Application No. 2,730,263 (4 pages). |
Mexican Office Action received foreign associate dated Aug. 8, 2013 for related Mexican Appln. No. MX/a/2011/000977. |
Number | Date | Country | |
---|---|---|---|
20190240389 A1 | Aug 2019 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12180324 | Jul 2008 | US |
Child | 16385162 | US |